Milestone Scientific (MLSS) Equity Average (2011 - 2026)

Milestone Scientific has disclosed Equity Average across 16 years of filings, most recently posting $2.5 million for Q1 2026.

• Equity Average for Q1 2026 came in at $2.5 million, down 50.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (down 50.49% YoY), and the FY2025 annual result was $4.3 million, down 37.56% from the prior year.
• Equity Average came in at $2.5 million for Q1 2026 at Milestone Scientific, down from $2.7 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $15.5 million in Q1 2022 to a low of $2.5 million in Q1 2026.
• The 5-year median for Equity Average is $7.6 million (2024), against an average of $7.7 million.
• Across the five-year window, Equity Average advanced 3.27% in 2024 and slumped 61.19% in 2025, its largest moves.
• Milestone Scientific's Equity Average stood at $10.6 million in 2022, then retreated by 29.18% to $7.5 million in 2023, then declined by 13.0% to $6.5 million in 2024, then slumped by 58.92% to $2.7 million in 2025, then dropped by 4.93% to $2.5 million in 2026.
• The last three Equity Average figures came in at $2.5 million (Q1 2026), $2.7 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.